BioSpace News Archive

Policy

Prestigious Cancer Centers Johns Hopkins and Moffitt Complete Patient Enrollment in Post Approval Study for MarginProbe®, Transforming the Standard of Care for Breast Cancer Patients

Dune Medical Devices has reached another milestone in their MarginProbe® Post Approval Study as Johns Hopkins Hospital and Moffitt Cancer Center complete their patient enrollments for the trial.

June 25, 2019
·
3 min read
Policy

NuSight Medical Announces Issuance of U.S. Patent Covering the NuLids System® for Treating Dry Eye Disease

Issuance of U.S. Patent No. 10,314,763 Bolsters NuSight Medical’s Intellectual Patent Portfolio

June 25, 2019
·
2 min read
Biotech Bay

HighWire Supports CSHL, BMJ and Yale to Launch medRxiv

Scholarly publishing tech provider, HighWire, announced it is proud to support the founders of medRxiv, by providing the hosting and submissions technology that underpins the new preprint server.

June 25, 2019
·
3 min read
Pharm Country

Tyto Care Expands Availability of TytoHome to Best Buy Stores in California, Ohio, North Dakota and South Dakota

TytoHome, now available for retail exclusively in 30 Best Buy stores and already available nationwide at BestBuy.com, provides users more convenient access to health care with at-home, on-demand medical exams and virtual physician visits

June 25, 2019
·
3 min read
Pharm Country

Alcresta Therapeutics Announces Publication of Consensus Statement Supporting Access to RELiZORB®

Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel, enzyme-based products, announced the publication of a consensus statement supporting the clinical outcomes of RELiZORB® and advocating for improved payer coverage and patient access.

June 25, 2019
·
3 min read
Business

CipherHealth’s New Clinical Advisory Board to Lead the Way to Better Patient Outcomes

Eight Top Healthcare Industry Leaders to Guide Best Practices for Engaging Patients and Families

June 25, 2019
·
2 min read
Drug Development

I-Mab Announces Dosing of First Patient in a Phase I Clinical Trial of TJC4, a Potentially Differentiated CD47 Antibody, for the Treatment of Cancers in the United States

I-Mab Biopharma (“I-Mab”), a clinical stage biotech company exclusively focusing on discovery and development of innovative biologics in immuno-oncology and autoimmune diseases, announces on June 24, 2019, that the first patient has been dosed in a Phase I clinical trial of TJC4.

June 25, 2019
·
3 min read
Business

SENTÉ® Appoints Adelle Walker as Chief Marketing Officer

SENTÉ®, a privately held specialty aesthetics company pioneering the development of differentiated medical grade skincare products based on patented Heparan Sulfate Analog technology, announces the appointment of Adelle Walker as Chief Marketing Officer.

June 25, 2019
·
2 min read
Policy

Government of Canada supports diabetes prevention in Alberta, Ontario and Quebec

Diabetes Prevention Program will help up to 3,850 individuals make healthy lifestyle changes

June 25, 2019
·
4 min read
Business

Centauri CEO Adam Miller Named EY Entrepreneur Of The Year® 2019 Award Winner in the Mountain Desert Region

Centauri Health Solutions Co-Founder and CEO Adam Miller has been selected as the EY Entrepreneur Of The Year® 2019 Award winner in the Healthcare category for the Mountain Desert Region, encompassing Arizona, Colorado and New Mexico.

June 25, 2019
·
3 min read